A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease
暂无分享，去创建一个
J. Butman | C. Brewer | C. Zalewski | R. Wesley | A. Chakraborty | C. Sibley | N. Plass | K. King | R. Bishop | D. Stone | D. Chapelle | Christopher Snyder | R. Goldbach-Mansky | H. Kim | K. Abrams | L. Colin | A. Chioato | S. Felix | Jackeline Rodriguez‐Smith | B. Kost